Merck, a leading science and technology company, today launched a beta version of M-Trust™, a secure cyber-physical trust ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...

M-Trust set to improve product safety and counterfeiting solutions Merck has launched the beta version of M-Trust, a ...

WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks ...

WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...

MSD has spent €500M acquiring a Dundalk vaccine plant and several other facilities around Ireland in an early year boost for ...

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

The construction chemicals market has been experiencing significant growth, which in turn, is impacting the trimer acid ...

Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.

A new, two-step strategy for making substituted piperidines offers chemists a more efficient way to make these biologically ...